©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Pediatr. Jun 9, 2024; 13(2): 92813
Published online Jun 9, 2024. doi: 10.5409/wjcp.v13.i2.92813
Published online Jun 9, 2024. doi: 10.5409/wjcp.v13.i2.92813
Mast cell activation syndrome: An up-to-date review of literature
Öner Özdemir, Department of Pediatric Allergy and Immunology, Sakarya University, Sakarya, Adapazarı 54100, Türkiye
Gökçe Kasımoğlu, Ayşegül Bak, Department of Pediatrics, Sakarya University, Sakarya, Adapazarı 54100, Türkiye
Hüseyin Sütlüoğlu, Department of Pediatrics, Kocaeli City Hospital, Kocaeli 50123, Türkiye
Süreyya Savaşan, Department of Pediatrics, Children’s Hospital of Michigan, Hemato
Süreyya Savaşan, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI 12345, United States
Author contributions: Özdemir Ö, Kasımoğlu G, Bak A design, conceptualization, methodology; Kasımoğlu G, Bak A data curation, research, writing-original draft preparation; Sütlüoğlu H, Savaşan S analysis and investigation; Özdemir Ö, Savaşan S supervision; Sütlüoğlu H software, validation; all authors writing-reviewing and editing.
Conflict-of-interest statement: The authors whose names are listed above, certify that they have no affiliations with or involvement in any organization or entity with any financial interest, or non-financial interest in the subject matter or materials discussed in this article.
Corresponding author: Öner Özdemir, MD, Professor, Department of Pediatric Allergy and Immunology, Sakarya University, Adnan Menderes cad, Sakarya, Adapazarı 54100, Türkiye. ozdemir_oner@hotmail.com
Received: February 6, 2024
Revised: May 3, 2024
Accepted: May 28, 2024
Published online: June 9, 2024
Processing time: 122 Days and 1.9 Hours
Revised: May 3, 2024
Accepted: May 28, 2024
Published online: June 9, 2024
Processing time: 122 Days and 1.9 Hours
Core Tip
Core Tip: Mast cell activation syndrome is a rare disease that is mostly diagnosed based on clinical symptoms. It is a disorder that should be considered with specific signs and symptoms of mast cell activation in individuals with skin, gastrointestinal, cardiovascular, respiratory, and neurological system involvement.